#India #Edinburgh #Bioinformatics #Fios Genomics #Excelra

Fios Genomics Bioinformatics Services Migrate to Excelra

In a significant development within the realm of scientific informatics, Excelra has announced the integration of Fios Genomics Ltd's bioinformatics services and team as of October 20, 2026. This transition marks a pivotal moment in enhancing Excelra's expertise in omics analyses and expanding its influence in both the UK and Europe.

Founded nearly two decades ago, Fios Genomics has been at the forefront of transforming complex omics data into valuable insights for researchers across pharmaceutical, biotech, and various life sciences sectors. The integration of Fios into Excelra aims to ensure continuity in service for its existing clients while amplifying the scientific capabilities and resources available to them. Sarah Lynagh, CEO of Fios Genomics, emphasized the commitment to maintaining high standards in scientific quality and rigorous methodology, which has defined Fios's operations for years. She noted, "Excelra shares these values and enhances our capabilities in data science and scientific informatics, enabling us to better serve our collaborators."

The alignment between Fios’s meticulous analytical approach and Excelra's existing data-driven methodologies is expected to yield a profound impact on how scientific inquiries are addressed, particularly in the context of multi-omic integration, translational knowledge, and the application of artificial intelligence in scientific research. Jannick Bendtsen, Vice President of Bioinformatics at Excelra, stated, "Fios's reputation for delivering rapid and clear analyses perfectly suits the needs of researchers handling complex datasets. This seamless integration will allow us to support our clients more efficiently and effectively."

Moreover, Anandbir Singh Brar, CEO of Excelra, expressed enthusiasm about welcoming the Fios team, which is trusted by clients for addressing their most intricate queries. He highlighted how Fios's scientific depth combined with Excelra’s bioinformatics and data management capabilities positions them to tackle key analytical questions related to targets, indications, and patient selection in a more timely and confident manner.

As the field of omics data continues to expand in volume, the core questions researchers grapple with remain constant. This partnership between Fios and Excelra promises not just to sustain that inquisitive spirit but also to elevate it, providing deeper insights and more robust solutions through enhanced collaboration and access to superior data assets.

The clients of Fios can continue to reach out to the team via [email protected].

About Excelra

Excelra blends AI-driven R&D confidence with intelligent data management and multi-omic expertise to convert the complexities of research and development into actionable insights supported by data-driven decisions. With a strong focus on scientific integrity and result-oriented approaches, Excelra aims to empower researchers and innovators globally.

About Fios Genomics

Established in 2008 as a spin-off from the University of Edinburgh, Fios Genomics has been dedicated to delivering bioinformatics analysis and biological interpretation in genomics, transcriptomics, and multi-omic studies, serving researchers in the pharmaceutical, biotech, and life sciences sectors worldwide.